REDWOOD CITY, Calif., April 12, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, is scheduled to present at the 18th Annual BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 15, at 10:30 a.m. Eastern time in New York City.
A live webcast of the presentation will be available under the Webcasts section of the Company's website.
A replay of the presentation will be archived on the site for 90 days.
About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website ().
CONTACT: Denise T. Powell Sr. Director, Corporate Communications Threshold Pharmaceuticals, Inc. 650-474-8206 firstname.lastname@example.org